InsiderTrades.com logo
See how to make money instead of spending it on Black Friday with this offer
From Legacy Research   |   Ad
Ph.D. Economist and Investor Nomi Prins is releasing details on her next stunning prediction…

It involves “liquid energy” that is promising to trigger an energy revolution 117x bigger than all of the hottest tech trends combined. Even the world’s richest billionaires are investing in the tiny company behind it.

And today, you can get in on this cutting-edge financial research at an incredible price tailor-made for Black Friday.
Get Nomi’s latest stock market prediction for $19

ELDN Insider Trading

Insider Ownership Percentage: 13.80%
Insider Buying (Last 12 Months): $8,960.00
Insider Selling (Last 12 Months): $0.00

Eledon Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Eledon Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Eledon Pharmaceuticals Share Price & Price History

Current Price: $2.51
Price Change: +0.30 (1.20%)
As of 11/25/2022 01:00 AM ET

This chart shows the closing price history over time for ELDN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
See how to make money instead of spending it on Black Friday with this offer
From Legacy Research   |   Ad
Ph.D. Economist and Investor Nomi Prins is releasing details on her next stunning prediction…

It involves “liquid energy” that is promising to trigger an energy revolution 117x bigger than all of the hottest tech trends combined. Even the world’s richest billionaires are investing in the tiny company behind it.

And today, you can get in on this cutting-edge financial research at an incredible price tailor-made for Black Friday.
Get Nomi’s latest stock market prediction for $19

Eledon Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/20/2021David-Alexandre C. GrosCEOBuy2,000$4.48$8,960.00View SEC Filing Icon  
8/17/2021David-Alexandre C. GrosCEOBuy4,000$6.21$24,840.007,000View SEC Filing Icon  
6/9/2021David-Alexandre C. GrosCEOBuy3,000$8.01$24,030.003,000View SEC Filing Icon  
See Full Table
See how to make money instead of spending it on Black Friday with this offer
From Legacy Research   |   Ad
Ph.D. Economist and Investor Nomi Prins is releasing details on her next stunning prediction…

It involves “liquid energy” that is promising to trigger an energy revolution 117x bigger than all of the hottest tech trends combined. Even the world’s richest billionaires are investing in the tiny company behind it.

And today, you can get in on this cutting-edge financial research at an incredible price tailor-made for Black Friday.
Get Nomi’s latest stock market prediction for $19

SEC Filings (Institutional Ownership Changes) for Eledon Pharmaceuticals (NASDAQ:ELDN)

47.53% of Eledon Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ELDN by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Eledon Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/15/2022Ensign Peak Advisors Inc87,286$0.24M0.0%+13.2%0.634%Search for SEC Filing on Google Icon
11/14/2022Cormorant Asset Management LP1,223,500$3.38M0.2%-6.3%8.894%Search for SEC Filing on Google Icon
11/14/2022Point72 Asset Management L.P.375,000$1.04M0.0%-12.5%2.726%Search for SEC Filing on Google Icon
11/14/2022Boothbay Fund Management LLC22,050$61K0.0%-36.3%0.160%Search for SEC Filing on Google Icon
11/10/2022Dimensional Fund Advisors LP17,950$50K0.0%N/A0.130%Search for SEC Filing on Google Icon
11/4/2022CM Management LLC245,000$0.68M0.8%+8.9%1.781%Search for SEC Filing on Google Icon
8/16/2022Woodline Partners LP516,675$1.26M0.0%-23.2%3.755%Search for SEC Filing on Google Icon
8/15/2022Point72 Asset Management L.P.428,360$1.05M0.0%-22.9%3.114%Search for SEC Filing on Google Icon
8/13/2022Renaissance Technologies LLC32,173$79K0.0%+74.2%0.234%Search for SEC Filing on Google Icon
5/16/2022Woodline Partners LP673,138$2.65M0.0%-13.9%4.893%Search for SEC Filing on Google Icon
5/16/2022State Street Corp44,692$0.18M0.0%+10.5%0.325%Search for SEC Filing on Google Icon
5/13/2022Renaissance Technologies LLC18,473$73K0.0%+35.1%0.134%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.679,243$2.68M0.0%+1.4%4.936%Search for SEC Filing on Google Icon
5/9/2022CM Management LLC225,000$0.89M0.7%+95.7%1.636%Search for SEC Filing on Google Icon
4/25/2022Bailard Inc.27,600$0.11M0.0%N/A0.193%Search for SEC Filing on Google Icon
2/14/2022Point72 Asset Management L.P.431,435$1.90M0.0%+105.9%3.016%Search for SEC Filing on Google Icon
2/11/2022Ensign Peak Advisors Inc77,100$0.34M0.0%+966.7%0.539%Search for SEC Filing on Google Icon
2/7/2022Ameritas Advisory Services LLC24,219$0.11M0.0%N/A0.169%Search for SEC Filing on Google Icon
2/2/2022CM Management LLC115,000$0.51M0.4%+53.3%0.804%Search for SEC Filing on Google Icon
11/16/2021Two Sigma Advisers LP115,900$0.72M0.0%+48.0%0.810%Search for SEC Filing on Google Icon
11/16/2021Two Sigma Investments LP115,324$0.71M0.0%+100.5%0.806%Search for SEC Filing on Google Icon
11/16/2021BVF Inc. IL1,363,435$8.43M0.3%+22.5%9.530%Search for SEC Filing on Google Icon
11/15/2021Point72 Asset Management L.P.209,490$1.30M0.0%+11.0%1.464%Search for SEC Filing on Google Icon
11/15/2021Eversept Partners LP114,008$0.71M0.1%N/A0.797%Search for SEC Filing on Google Icon
11/15/2021Ensign Peak Advisors Inc7,228$45K0.0%-80.0%0.051%Search for SEC Filing on Google Icon
11/10/2021Mercer Global Advisors Inc. ADV16,726$0.10M0.0%N/A0.117%Search for SEC Filing on Google Icon
8/18/2021Ikarian Capital LLC350,000$2.77M0.2%+40.0%2.446%Search for SEC Filing on Google Icon
8/17/2021Woodline Partners LP857,445$6.78M0.1%-3.8%5.993%Search for SEC Filing on Google Icon
8/17/2021Boothbay Fund Management LLC40,052$0.32M0.0%+39.6%0.280%Search for SEC Filing on Google Icon
8/16/2021Point72 Asset Management L.P.188,690$1.49M0.0%+51.0%1.319%Search for SEC Filing on Google Icon
8/16/2021Morgan Stanley851,004$6.73M0.0%+7,235.6%5.948%Search for SEC Filing on Google Icon
8/16/2021State Street Corp32,935$0.26M0.0%N/A0.230%Search for SEC Filing on Google Icon
8/13/2021Renaissance Technologies LLC21,107$0.17M0.0%-22.0%0.148%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp32,116$0.25M0.0%+106.8%0.224%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC124,614$0.99M0.0%+25.7%0.871%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.209,750$1.66M0.0%-8.8%1.466%Search for SEC Filing on Google Icon
5/19/2021Logos Global Management LP224,071$2.40M0.2%N/A1.566%Search for SEC Filing on Google Icon
5/18/2021BVF Inc. IL1,113,435$11.91M0.4%N/A7.782%Search for SEC Filing on Google Icon
5/18/2021Millennium Management LLC14,588$0.16M0.0%N/A0.102%Search for SEC Filing on Google Icon
5/18/2021Point72 Asset Management L.P.125,000$1.34M0.0%N/A0.874%Search for SEC Filing on Google Icon
5/18/2021Cormorant Asset Management LP1,415,500$15.15M0.3%N/A9.894%Search for SEC Filing on Google Icon
5/18/2021Citadel Advisors LLC25,062$0.27M0.0%N/A0.175%Search for SEC Filing on Google Icon
5/17/2021Woodline Partners LP891,055$9.53M0.2%N/A6.228%Search for SEC Filing on Google Icon
5/17/2021EcoR1 Capital LLC1,115,721$11.94M0.5%N/A7.798%Search for SEC Filing on Google Icon
5/17/2021Janus Henderson Group PLC213,899$2.25M0.0%N/A1.495%Search for SEC Filing on Google Icon
5/17/2021Ikarian Capital LLC250,000$2.68M0.1%N/A1.747%Search for SEC Filing on Google Icon
5/13/2021Renaissance Technologies LLC27,051$0.29M0.0%N/A0.189%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp15,528$0.17M0.0%N/A0.109%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC99,123$1.06M0.0%N/A0.693%Search for SEC Filing on Google Icon
5/12/2021CM Management LLC75,000$0.80M0.6%N/A0.524%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.12,282$0.13M0.0%N/A0.086%Search for SEC Filing on Google Icon
4/21/2021Ingalls & Snyder LLC51,149$0.55M0.0%N/A0.358%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Eledon Pharmaceuticals logo
Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that is a molecule expressed on the surface of human immune system T cells, which is in Phase 2a clinical trials for the treatment of ALS, and Phase 2 clinical trials in islet cell transplantation for the treatment of type 1 diabetes. The company was formerly known as Novus Therapeutics, Inc. and changed its name to Eledon Pharmaceuticals, Inc. in January 2021. Eledon Pharmaceuticals, Inc. is headquartered in Irvine, California.
Read More on Eledon Pharmaceuticals

Today's Range

Now: $2.51
Low: $2.51
High: $2.51

50 Day Range

MA: $2.59
Low: $2.31
High: $3.32

52 Week Range

Now: $2.51
Low: $2.27
High: $5.32

Volume

59 shs

Average Volume

12,642 shs

Market Capitalization

$34.54 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.86

Who are the company insiders with the largest holdings of Eledon Pharmaceuticals?

Eledon Pharmaceuticals' top insider shareholders include:
  1. David-Alexandre C Gros (CEO)
  2. David-Alexandre C Gros (CEO)
  3. Paul Sean Little (CFO)
Learn More about top insider investors at Eledon Pharmaceuticals.

Who are the major institutional investors of Eledon Pharmaceuticals?

Eledon Pharmaceuticals' top institutional investors include:
  1. Cormorant Asset Management LP — 8.89%
  2. Point72 Asset Management L.P. — 2.73%
  3. CM Management LLC — 1.78%
  4. Ensign Peak Advisors Inc — 0.63%
  5. Boothbay Fund Management LLC — 0.16%
  6. Dimensional Fund Advisors LP — 0.13%
Learn More about top institutional investors of Eledon Pharmaceuticals stock.

Which major investors are selling Eledon Pharmaceuticals stock?

In the last quarter, ELDN stock was sold by these institutional investors:
  1. Cormorant Asset Management LP
  2. Point72 Asset Management L.P.
  3. Boothbay Fund Management LLC

Which major investors are buying Eledon Pharmaceuticals stock?

Within the last quarter, ELDN stock was acquired by institutional investors including:
  1. CM Management LLC
  2. Dimensional Fund Advisors LP
  3. Ensign Peak Advisors Inc
During the previous year, these company insiders have bought Eledon Pharmaceuticals stock:
  1. David-Alexandre C Gros (CEO)
  2. David-Alexandre C Gros (CEO)
  3. Paul Sean Little (CFO)
Learn More investors buying Eledon Pharmaceuticals stock.
See how to make money instead of spending it on Black Friday with this offer
From Legacy Research   |   Ad
Ph.D. Economist and Investor Nomi Prins is releasing details on her next stunning prediction…

It involves “liquid energy” that is promising to trigger an energy revolution 117x bigger than all of the hottest tech trends combined. Even the world’s richest billionaires are investing in the tiny company behind it.

And today, you can get in on this cutting-edge financial research at an incredible price tailor-made for Black Friday.
Get Nomi’s latest stock market prediction for $19